Bumrungrad Hospital Bangladesh Office

Lung Cancer Diagnosis and Treatment at Bumrungrad

Lung Cancer Diagnosis and Treatment at Bumrungrad: When to Travel from Bangladesh

A lung cancer diagnosis is one of the most frightening things a family can face. The first reaction is often panic, followed by a flood of questions. Is the diagnosis correct? Is treatment available here? Should we go abroad? How quickly do we need to act?

This guide answers those questions honestly, without pushing you toward a decision that isn’t right for your situation. It explains what Bumrungrad International Hospital offers for lung cancer patients, what treatment looks like in Bangladesh, and the specific circumstances under which traveling to Bangkok is genuinely the better choice.

Lung Cancer in Bangladesh: The Real Picture

Lung cancer is one of the most common cancers in Bangladesh. Around 8.2% of newly diagnosed cancer patients in Bangladesh have lung cancer, which translates to over 12,000 new cases annually. Smoking remains the dominant cause, responsible for approximately 80% of all diagnosed cases. Air pollution, tuberculosis history, family history, and occupational exposure to asbestos or silica are contributing factors for the remaining cases.

The biggest clinical problem in Bangladesh is late diagnosis. Research published in medical literature shows that the median time from symptom onset to diagnosis in Bangladesh is approximately 121 days. That’s four months. Lung cancer is most treatable when caught at Stage 1 or Stage 2. By the time most Bangladeshi patients receive a confirmed diagnosis, many are already at Stage 3 or Stage 4.

This delay happens for two reasons. First, early lung cancer produces no symptoms at all. Second, the symptoms it does eventually produce, such as a persistent cough, mild breathlessness, or chest discomfort, are easy to dismiss as bronchitis, a chest infection, or the effects of air pollution. Many patients spend weeks treating a “cough” before any imaging is ordered.

Warning Signs You Should Not Ignore

Because early-stage lung cancer has no obvious symptoms, understanding which signs warrant urgent investigation is critical. See a doctor and request a chest imaging scan if you or someone in your family has:

  • A cough that doesn’t go away after 3 to 4 weeks, or one that is getting progressively worse
  • Blood in the phlegm or sputum, even in small amounts
  • Chest pain that doesn’t go away, particularly on deep breathing or coughing
  • Unexplained weight loss of 5 kg or more over a short period
  • Persistent hoarseness or a change in voice
  • Shortness of breath that is getting worse over weeks
  • Recurrent pneumonia or chest infections that keep returning after treatment
  • Swelling in the face, neck, or upper chest

None of these symptoms alone confirms lung cancer. However, any of these symptoms that persist for more than 3 weeks in someone with a significant smoking history, a family history of lung cancer, or prolonged exposure to air pollution should be investigated with a low-dose CT scan, not just a chest X-ray.

Why a Chest X-Ray Is Not Enough for Lung Cancer Screening

This is one of the most important practical points for Bangladeshi patients. A standard chest X-ray can only detect large tumors, and even then only when the tumor is not hidden behind the heart, bones, or other lung tissue. Small tumors, which are the ones most treatable, are routinely missed on standard X-ray.

Low-dose computed tomography (low-dose CT) is the correct screening tool for lung cancer. It produces three-dimensional, high-resolution images of the lung with significantly less radiation than a standard CT scan. It can detect abnormalities as small as a few millimetres, long before they are visible on an X-ray.

Low-dose CT screening is recommended for:

  • Current smokers or people who quit within the last 15 years
  • Anyone between 50 and 80 years old with a history of heavy smoking (approximately one pack per day for 20 years)
  • People with a first-degree family member diagnosed with lung cancer
  • Anyone with chronic lung conditions such as COPD or previous tuberculosis

If your local doctor has not suggested low-dose CT screening and you fall into these categories, ask for it directly. Bumrungrad’s Pulmonary Center offers low-dose CT lung screening as part of its diagnostic capabilities.

What Lung Cancer Diagnosis at Bumrungrad Involves

If you arrive at Bumrungrad with a suspected lung cancer based on imaging done in Bangladesh, or if you come for a second opinion on a diagnosis already made locally, the diagnostic workup will typically include the following.

PET/CT Scan: A PET scan combined with CT gives information about both the structure and metabolic activity of any abnormal tissue. It shows how far the cancer has spread, and it’s a critical staging tool that many hospitals in Bangladesh don’t have access to or have limited availability for.

Molecular and Genetic Testing (Biomarker Testing): This is where Bumrungrad’s advantage over most Bangladeshi hospitals becomes most clinically significant. Lung cancer is not one disease. It has multiple subtypes, and within those subtypes, specific genetic mutations drive the cancer’s growth. Testing for mutations such as EGFR, ALK, ROS1, KRAS, and PD-L1 tells the oncologist which targeted therapy or immunotherapy has the highest chance of working for your specific cancer. Without this testing, treatment is essentially a guess.

Many patients in Bangladesh receive standard chemotherapy without biomarker testing, simply because the testing infrastructure isn’t widely available or the result interpretation isn’t actionable at the local level. At Bumrungrad, molecular profiling is standard for lung cancer workup. The results directly shape the treatment plan.

Bronchoscopy: A flexible camera passed through the airway to take a direct biopsy of suspected lung tumors or lymph nodes. Bumrungrad performs this with advanced navigational bronchoscopy techniques.

Biopsy: Tissue is required to confirm the diagnosis and perform molecular testing. Depending on the tumor’s location, this may be done via bronchoscopy, CT-guided needle biopsy, or a surgical biopsy.

All of these investigations are coordinated through the Bumrungrad Pulmonary Center and the Horizon Regional Cancer Center working together. The two centers share patient management for lung cancer to ensure the diagnostic workup and treatment plan are developed by the right combination of specialists.

How Bumrungrad Treats Lung Cancer

Treatment at Bumrungrad is determined by a multidisciplinary team. For lung cancer, this includes a pulmonologist, a medical oncologist, a radiation oncologist, a thoracic surgeon, and a radiologist. They review each case together and agree on a treatment plan before presenting it to the patient. This is called tumor board review, and it’s standard practice at Bumrungrad but not universally available in Bangladesh.

Surgery

For early-stage lung cancer (Stage 1 and Stage 2), surgery to remove the tumor and surrounding tissue is the primary curative treatment. Bumrungrad performs thoracic surgery including lobectomy (removing a lobe of the lung), wedge resection (removing a smaller section), and pneumonectomy (removing an entire lung) when necessary. Minimally invasive video-assisted thoracic surgery (VATS) is available, which reduces recovery time and complications significantly compared to open chest surgery.

Surgery is typically followed by adjuvant chemotherapy or targeted therapy to eliminate any remaining cancer cells.

Targeted Therapy

If biomarker testing identifies a specific mutation driving the cancer, targeted therapy is used instead of or alongside chemotherapy. Targeted drugs attack the specific molecular pathway causing the cancer to grow, with significantly fewer side effects than standard chemotherapy. EGFR inhibitors such as osimertinib, ALK inhibitors, and other agents are all available at Bumrungrad.

This is one of the most compelling reasons Bangladeshi patients with non-small cell lung cancer (NSCLC) come to Bumrungrad. The targeted therapy itself may theoretically be available in Bangladesh, but the full diagnostic pathway to determine whether you’re eligible, and the oncology team experienced in managing its side effects and response monitoring, is more consistently available at Bumrungrad.

Immunotherapy

For patients whose cancer shows high PD-L1 expression, immunotherapy using checkpoint inhibitors such as pembrolizumab can significantly extend survival, particularly in advanced-stage disease. Bumrungrad’s oncology team has extensive experience with immunotherapy protocols. More information on the oncology specialists is on our hematology and oncology page.

Chemotherapy

Standard chemotherapy remains part of treatment for many lung cancer patients, either as the primary approach for small cell lung cancer (SCLC), as adjuvant therapy after surgery, or in combination with radiation for locally advanced disease. Bumrungrad offers personalized chemotherapy protocols based on the patient’s cancer type, stage, overall health, and molecular profile.

Radiation Therapy

Bumrungrad offers volumetric-modulated arc therapy (VMAT) and stereotactic body radiation therapy (SBRT), which deliver precise doses of radiation to the tumor while protecting surrounding healthy lung tissue. SBRT is particularly useful for patients who cannot undergo surgery due to age, lung function, or other health conditions.

When Should a Bangladeshi Patient Travel to Bumrungrad for Lung Cancer?

This is the most important question in this guide, and it deserves a direct answer rather than a general one.

Travel to Bumrungrad when:

  • Your local diagnosis involved only chest X-ray and basic CT without PET staging or molecular testing
  • You want a confirmed second opinion from a specialist team before starting treatment
  • Your oncologist in Bangladesh has recommended chemotherapy but hasn’t tested for targetable mutations
  • You’ve been told surgery is possible but want confirmation from a thoracic surgeon with greater volume experience
  • You’re at Stage 3A or 3B and want to explore whether a combination approach (surgery, targeted therapy, immunotherapy) is possible
  • You or your family are not confident in the current treatment plan and want a tumor board review

You may not need to travel if:

  • Your diagnosis is confirmed, the staging is complete including PET, biomarker testing has been done, and the treatment plan is clear
  • You’re already on a targeted therapy that is working and your local oncology team can manage it
  • You’re at Stage 4 with widespread disease and the focus has shifted to palliative care and quality of life

The honest answer is that Stage 4 lung cancer, where the cancer has spread to multiple organs, is not curable anywhere in the world. Bumrungrad can offer treatments that extend survival and improve quality of life, including combination immunotherapy and targeted therapy, but no hospital can cure widely metastatic lung cancer. If a patient is at Stage 4, the decision to travel should be made with full understanding of what is and isn’t achievable.

For Stage 1, Stage 2, and selected Stage 3 patients, Bumrungrad offers a meaningfully better diagnostic workup and treatment pathway than what is consistently available in Bangladesh.

Traveling to Bumrungrad for Lung Cancer: What to Bring

If you’re coming to Bumrungrad for a second opinion or to begin treatment, bring everything you have:

  • All CT and PET scan images on CD or USB, not just printed reports
  • Pathology reports and biopsy slides (the actual glass slides if possible, as Bumrungrad may re-stain and re-review them)
  • Any molecular or genetic testing results already done
  • Blood test results from the last 3 months
  • A summary letter from your current treating doctor
  • Current medication list with dosages
  • Your passport with at least 6 months of remaining validity

ThaiMediXpress coordinates the submission of these documents to the Bumrungrad Pulmonary Center before you arrive. The specialist reviews them and prepares a preliminary case assessment, which helps you understand what additional workup Bumrungrad would recommend and what the treatment plan would look like. For critical patients who cannot travel by commercial flight, emergency air ambulance from Bangladesh to Bumrungrad is available 24 hours a day through our coordination team.

A Note for Families in Chittagong

Our Chittagong office serves patients from Chattogram Division, Cox’s Bazar, Comilla, Feni, and the southeastern districts. Lung cancer patients from this region can arrange pre-travel coordination, visa support, and air ambulance if needed directly through the Chittagong team. You do not need to go through Dhaka. Visit our Bumrungrad Chittagong office page or call 01844 047063 directly.

Frequently Asked Questions

Can Bumrungrad treat Stage 4 lung cancer patients from Bangladesh?

Answer: Yes. Bumrungrad treats Stage 4 lung cancer patients regularly with a combination of targeted therapy, immunotherapy, and palliative approaches. The goal at Stage 4 is typically to extend survival and maintain quality of life, not to cure. Bumrungrad’s molecular profiling gives Stage 4 patients the best chance of identifying a targeted drug that their cancer responds to.

How long would a Bangladeshi lung cancer patient need to stay in Bangkok?

Answer: For diagnostic workup and treatment planning only, a stay of 5 to 7 days is usually sufficient. For surgery plus initial recovery, plan for 10 to 14 days. For chemotherapy or targeted therapy, many patients return to Bangladesh between cycles and come back for each cycle, reducing the total time spent in Bangkok at any one stretch.

Does Bumrungrad have Bengali-speaking staff for lung cancer patients?

Answer: Yes. Bumrungrad has Bengali-speaking coordinators specifically for Bangladeshi patients. ThaiMediXpress also remains in contact throughout the treatment journey, so you always have someone who speaks Bengali on both the Bangladesh side and at the hospital.

Is a second opinion from Bumrungrad worth it if treatment has already started in Bangladesh?

Answer: In many cases, yes. If biomarker testing has not been done, a Bumrungrad second opinion may identify a targetable mutation that changes the entire treatment approach. It’s not about criticizing your local doctor. It’s about having the most complete information before committing to a long treatment course.

How do I start the process with ThaiMediXpress for a lung cancer case?

Answer: Contact our Dhaka office at 01844047060 or our Chittagong office at 01844 047063 via call or WhatsApp. Send us your current imaging and reports. We forward them to Bumrungrad’s Pulmonary Center and Horizon Cancer Center for preliminary review. You’ll receive a response within 3 to 7 working days, completely free of charge.

Thai Medi Xpress is the official referral partner of Bumrungrad International Hospital in Bangladesh, operating from Dhaka and Chittagong since 2018. All coordination services are free. Contact us at 01844047060 (Dhaka) or 01844 047063 (Chittagong).

 

Scroll to Top